Min. Order: | 1 Gram |
---|
Model No.: 957054-33-0
Brand: Conbottpharm
Packaging: As required
Productivity: Customized
Place of Origin: China
Supply Ability: Commercial
Certificate: Documents Support
We are professional GDC-0941 Bimesylate CAS 957054-33-0 manufacture, exporter and supplier from China. GDC-0941 Bimesylate is also called GDC-0941, GDC0941 and GDC-0941 Dimethanesulfonate, which is a novel selective class I phosphatidylinositol-3-kinase (PI3K) inhibitor. Activation of PI3K/Akt signaling pathway is frequently associated with tumorigenesis. Deregulation of this pathway occurs frequently with a variety of cancers and may contribute to the resistance to many anticancer agents. We hold certain inventory to meet customers requirements. We can offer different package and arrange shipment fast.
Thera. Category: Starting material for organic synthesis.
Cas No.: 27665-39-0
Synonym: GDC-0941 Bimesylate;GDC-0941 (diMethanesulfonate);GDC 0941 (2 MeSO3H salt);GDC-0941 (2 MeSO3H salt);Pictilisib;GDC-0941 BiMesylate/pictilisib;2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine methanesulfonate (1:2);Pictilisib (GDC-0941)
Molecular Formula: C4H10O6S2
Molecular Weight: 218.2
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: GDC-0941 is a novel selective class I phosphatidylinositol-3-kinase (PI3K) inhibitor. Activation of PI3K/Akt signaling pathway is frequently associated with tumorigenesis. Deregulation of this pathway occurs frequently with a variety of cancers and may contribute to the resistance to many anticancer agents.
Product Categories : Inhibitors > PI3K Inhibitors